Form D · Biotechnology
Intellect Neurosciences, Inc.
New York, NY · CIK 0001337905
Offering snapshot reported May 7, 2010 · SEC filing
- Reported sold
- $2.32M Offering amount: $2.32M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Apr 23, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 7, 2010 | Initial | $2,320,000 | No comparison | 7 | SEC filing |
| Sep 10, 2009 | Initial | $450,000 | No comparison | 1 | SEC filing |
| Feb 8, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-141669
Source: Form D, filed May 7, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Elliot Mitchell Maza | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7 West 18 Th Street
New York, NY, 10011
New York, NY, 10011